Jeffrey S. Parkin

Array ( [id] => 1445939 [patent_doc_number] => 06368604 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-09 [patent_title] => 'Non-pyrogenic derivatives of lipid A' [patent_app_type] => B1 [patent_app_number] => 08/938106 [patent_app_country] => US [patent_app_date] => 1997-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 18687 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/368/06368604.pdf [firstpage_image] =>[orig_patent_app_number] => 08938106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4244439 [patent_doc_number] => 06136561 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-24 [patent_title] => 'Methods of preparing carboxy-terminally truncated recombinant flavivirus envelope glycoproteins employing drosophila melanogaster expression systems' [patent_app_type] => 1 [patent_app_number] => 8/937195 [patent_app_country] => US [patent_app_date] => 1997-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 22240 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 164 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/136/06136561.pdf [firstpage_image] =>[orig_patent_app_number] => 937195 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1230433 [patent_doc_number] => 06692751 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-17 [patent_title] => 'Methods and systems for producing recombinant viral antigens' [patent_app_type] => B1 [patent_app_number] => 08/931855 [patent_app_country] => US [patent_app_date] => 1997-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 21215 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/692/06692751.pdf [firstpage_image] =>[orig_patent_app_number] => 08931855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1391044 [patent_doc_number] => 06548631 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-15 [patent_title] => 'Macrophage derived chemokine (MDC) as an anti-viral agent for the treatment and prevention of lentivirus infection' [patent_app_type] => B1 [patent_app_number] => 08/931764 [patent_app_country] => US [patent_app_date] => 1997-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 22691 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/548/06548631.pdf [firstpage_image] =>[orig_patent_app_number] => 08931764 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5827930 [patent_doc_number] => 20020068048 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-06 [patent_title] => 'METHOD FOR THE TREATMENT OR DIAGNOSIS OF HUMAN PATHOLOGIES WITH DISSEMINATED OR DIFFICULT TO ACCESS CELLS OR TISSUES' [patent_app_type] => new [patent_app_number] => 08/924830 [patent_app_country] => US [patent_app_date] => 1997-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5453 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20020068048.pdf [firstpage_image] =>[orig_patent_app_number] => 08924830 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4294184 [patent_doc_number] => 06235878 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-22 [patent_title] => 'Fas ligand-like protein, its production and use' [patent_app_type] => 1 [patent_app_number] => 8/913014 [patent_app_country] => US [patent_app_date] => 1997-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 26 [patent_no_of_words] => 46098 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/235/06235878.pdf [firstpage_image] =>[orig_patent_app_number] => 913014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4229461 [patent_doc_number] => 06165477 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-26 [patent_title] => 'Subunit immonogenic composition against dengue infection' [patent_app_type] => 1 [patent_app_number] => 8/915152 [patent_app_country] => US [patent_app_date] => 1997-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 37120 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/165/06165477.pdf [firstpage_image] =>[orig_patent_app_number] => 915152 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4403268 [patent_doc_number] => 06238669 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-29 [patent_title] => 'Proteins encoded by chicken anemia virus DNA and diagnostic kits and vaccines employing said proteins' [patent_app_type] => 1 [patent_app_number] => 8/910322 [patent_app_country] => US [patent_app_date] => 1997-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 17 [patent_no_of_words] => 11586 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/238/06238669.pdf [firstpage_image] =>[orig_patent_app_number] => 910322 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 612468 [patent_doc_number] => 07147862 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-12-12 [patent_title] => 'Vaccine composition containing adjuvants' [patent_app_type] => utility [patent_app_number] => 08/909879 [patent_app_country] => US [patent_app_date] => 1997-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4238 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/147/07147862.pdf [firstpage_image] =>[orig_patent_app_number] => 08909879 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4416844 [patent_doc_number] => 06177081 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-23 [patent_title] => 'Human and marmoset activating viruses' [patent_app_type] => 1 [patent_app_number] => 8/901128 [patent_app_country] => US [patent_app_date] => 1997-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12499 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/177/06177081.pdf [firstpage_image] =>[orig_patent_app_number] => 901128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4393096 [patent_doc_number] => 06297003 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-02 [patent_title] => 'Methods for the detection of a novel hepatitis C virus (HCV) terminal 3\' noncoding region' [patent_app_type] => 1 [patent_app_number] => 8/897126 [patent_app_country] => US [patent_app_date] => 1997-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 23901 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/297/06297003.pdf [firstpage_image] =>[orig_patent_app_number] => 897126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1255886 [patent_doc_number] => 06667157 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-23 [patent_title] => 'Compositions and methods for the abrogation of cellular proliferation utilizing the human immunodeficiency virus VPR protein' [patent_app_type] => B1 [patent_app_number] => 08/809186 [patent_app_country] => US [patent_app_date] => 1997-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19636 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/667/06667157.pdf [firstpage_image] =>[orig_patent_app_number] => 08809186 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1208374 [patent_doc_number] => 06713064 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-30 [patent_title] => 'Immune enhancing agent for treating HIV infected humans' [patent_app_type] => B1 [patent_app_number] => 08/879099 [patent_app_country] => US [patent_app_date] => 1997-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3166 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/713/06713064.pdf [firstpage_image] =>[orig_patent_app_number] => 08879099 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4268992 [patent_doc_number] => 06306849 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-23 [patent_title] => 'Selected derivatives of K-252a' [patent_app_type] => 1 [patent_app_number] => 8/867084 [patent_app_country] => US [patent_app_date] => 1997-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 9 [patent_no_of_words] => 45758 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 724 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/306/06306849.pdf [firstpage_image] =>[orig_patent_app_number] => 867084 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4082880 [patent_doc_number] => 06025125 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-15 [patent_title] => 'Methods for the detection of HIV-specific immune responses employing non-infectious, non-replicating, IIV retrovirus-like particles containing heterologous antigenic markers' [patent_app_type] => 1 [patent_app_number] => 8/776949 [patent_app_country] => US [patent_app_date] => 1997-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 12056 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 184 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/025/06025125.pdf [firstpage_image] =>[orig_patent_app_number] => 776949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1486840 [patent_doc_number] => 06428792 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-06 [patent_title] => 'Hepatitis C virus multiple copy epitope fusion antigens' [patent_app_type] => B1 [patent_app_number] => 08/859524 [patent_app_country] => US [patent_app_date] => 1997-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 19 [patent_no_of_words] => 12667 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 184 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/428/06428792.pdf [firstpage_image] =>[orig_patent_app_number] => 08859524 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1523461 [patent_doc_number] => 06352826 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-05 [patent_title] => 'Method and kit for the detection of retroviral specific antibodies in seronegative individuals' [patent_app_type] => B1 [patent_app_number] => 08/855371 [patent_app_country] => US [patent_app_date] => 1997-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4425 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/352/06352826.pdf [firstpage_image] =>[orig_patent_app_number] => 08855371 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 481678 [patent_doc_number] => 07220420 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-22 [patent_title] => 'Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses' [patent_app_type] => utility [patent_app_number] => 08/854825 [patent_app_country] => US [patent_app_date] => 1997-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 10 [patent_no_of_words] => 16982 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/220/07220420.pdf [firstpage_image] =>[orig_patent_app_number] => 08854825 [rel_patent_id] =>[rel_patent_doc_number] =>)